AXQ Capital LP Buys Shares of 75,675 Bath & Body Works, Inc. $BBWI

AXQ Capital LP bought a new stake in Bath & Body Works, Inc. (NYSE:BBWI) during the fourth quarter, HoldingsChannel reports. The institutional investor bought 75,675 shares of the company’s stock, valued at approximately $1,520,000.

A number of other large investors have also modified their holdings of BBWI. Global Retirement Partners LLC acquired a new position in shares of Bath & Body Works during the fourth quarter worth $31,000. Activest Wealth Management acquired a new position in Bath & Body Works in the 4th quarter valued at $32,000. Geneos Wealth Management Inc. lifted its position in Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the period. Danske Bank A S acquired a new stake in Bath & Body Works in the third quarter valued at about $39,000. Finally, First Horizon Corp lifted its position in Bath & Body Works by 96.3% in the fourth quarter. First Horizon Corp now owns 2,218 shares of the company’s stock valued at $45,000 after purchasing an additional 1,088 shares during the period. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Price Performance

Shares of BBWI stock opened at $18.66 on Tuesday. The firm has a market capitalization of $3.76 billion, a P/E ratio of 5.24, a P/E/G ratio of 2.00 and a beta of 1.42. The company’s fifty day moving average price is $18.62 and its two-hundred day moving average price is $20.18. Bath & Body Works, Inc. has a 12 month low of $14.27 and a 12 month high of $33.96.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. The business had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The company’s revenue for the quarter was down 3.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, sell-side analysts anticipate that Bath & Body Works, Inc. will post 2.6 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, June 19th. Stockholders of record on Friday, June 5th will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.3%. The ex-dividend date is Friday, June 5th. Bath & Body Works’s dividend payout ratio is 22.47%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Barclays reduced their price objective on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a research report on Thursday. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Bath & Body Works from $21.00 to $22.00 and gave the stock a “hold” rating in a research note on Tuesday, March 3rd. Wells Fargo & Company dropped their price objective on shares of Bath & Body Works from $29.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. Piper Sandler assumed coverage on shares of Bath & Body Works in a research note on Friday, May 15th. They set a “neutral” rating and a $20.00 price objective for the company. Finally, Citigroup cut shares of Bath & Body Works from a “buy” rating to a “neutral” rating and raised their price objective for the stock from $21.00 to $25.00 in a research note on Tuesday, February 17th. Three research analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $21.93.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.